Duncker Streett & Co’s Elanco Animal Health ELAN Stock Holding History

Duncker Streett & Co’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$294	–	540
2025 Q4	$294	Hold	13	–	–	﹤0.01%	519
2025 Q3	$262	Hold	13	–	–	﹤0.01%	525
2025 Q2	$186	Hold	13	–	–	﹤0.01%	507
2025 Q1	$137	Hold	13	–	–	﹤0.01%	497
2024 Q4	$157	Hold	13	–	–	﹤0.01%	526
2024 Q3	$191	Hold	13	–	–	﹤0.01%	480
2024 Q2	$188	Hold	13	–	–	﹤0.01%	478
2024 Q1	$212	Hold	13	–	–	﹤0.01%	470
2023 Q4	$194	Hold	13	–	–	﹤0.01%	483
2023 Q3	$146	Hold	13	–	–	﹤0.01%	483
2023 Q2	$131	Buy	+13	New	+$121	﹤0.01%	499

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Duncker Streett & Co's ELAN Position: Q1 2026 in Review

Duncker Streett & Co sold out of Elanco Animal Health (ELAN) in Q1 2026, closing a stake of 13 shares — an estimated $294 sold.

Duncker Streett & Co first reported a position in ELAN in Q2 2023 and held it in 11 quarters. The position peaked at $294 in Q4 2025. 519 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Duncker Streett & Co reported no remaining Elanco Animal Health position as of Q1 2026 after selling out during the quarter.
Duncker Streett & Co sold 13 Elanco Animal Health shares in Q1 2026, an estimated $294.
Duncker Streett & Co first reported a position in Elanco Animal Health in Q2 2023 and held it in 11 quarters.
Duncker Streett & Co's Elanco Animal Health position peaked at $294 in Q4 2025.
519 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Duncker Streett & Co's 13F filing for Q1 2026, filed 29 Apr 2026.